O'Brien Patrick Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$18.59M

Insider Activity of O'Brien Patrick

According to the SEC Form 4 filings, O'Brien Patrick, being in a position of

  1. COO at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 49493 shares for $3.12M,
    over all time since 2019-01-18, has bought 0 shares, and sold 488492 shares for $21.71M.

Biography of O'Brien Patrick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,123,3491100

Comparison of Insiders on Amount of Buys and Sells

2026-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO
49,493
0.0354%
$63.11$3.12M+10.63%
2025-01-07SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
8,000
0.0065%
$19.69$157,520-3.08%
2025-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
29,184
0.0236%
$19.82$578,539-2.23%
2024-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
22,841
0.021%
$35.27$805,716-30.63%
2024-01-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
1,600
0.0014%
$32.63$52,208-28.47%
2024-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
8,749
0.0082%
$32.28$282,439-22.74%
2023-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
15,000
0.0142%
$37.39$560,850-17.88%
2023-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
COO and General Counsel
17,500
0.0163%
$38.33$670,802-20.9%
2022-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
32,500
0.0316%
$61.72$2.01M-34.2%
2021-02-08SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
90,000
0.0867%
$88.46$7.96M-24.08%
2021-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
25,000
0.0234%
$72.41$1.81M-7.92%
2020-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
14,625
0.0146%
$60.12$879,261-27.55%
2019-05-28SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
30,000
0.0314%
$24.88$746,400+36.81%
2019-01-18SaleArrowhead Pharmaceuticals, Inc.
ARWR
General Counsel
144,000
0.152%
$14.43$2.08M+93.94%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.